Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies

Samura, 2020, Update on noninvasive prenatal testing: a review based on current worldwide research, J Obstet Gynaecol Res, 46, 1246, 10.1111/jog.14268 Bianchi, 2018, Sequencing of circulating cell-free DNA during pregnancy, N Engl J Med, 379, 464, 10.1056/NEJMra1705345 Brady, 2016, Clinical implementation of NIPT - technical and biological challenges, Clin Genet., 89, 523, 10.1111/cge.12598 Ji, 2019, Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests, Genet Med, 21, 2293, 10.1038/s41436-019-0510-5 Dharajiya, 2018, Incidental detection of maternal neoplasia in noninvasive prenatal testing, Clin Chem, 64, 329, 10.1373/clinchem.2017.277517 Amant, 2015, Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing, JAMA Oncol, 1, 814, 10.1001/jamaoncol.2015.1883 Bianchi, 2015, Noninvasive prenatal testing and incidental detection of occult maternal malignancies, JAMA - J Am Med Assoc, 314, 162, 10.1001/jama.2015.7120 van der Meij, 2019, TRIDENT-2: national Implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands, Am J Hum Genet, 105, 1091, 10.1016/j.ajhg.2019.10.005 Lenaerts, 2019, Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing, Prenat Diagn, 39, 10.1002/pd.5544 Benn, 2019, Current controversies in prenatal diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed, Prenat Diagn, 39, 339, 10.1002/pd.5379 Giles, 2017, Prenatal cfDNA screening results indicative of maternal neoplasm: survey of current practice and management needs, Prenat Diagn, 37, 126, 10.1002/pd.4973 Carlson, 2018, Maternal malignancy evaluation after discordant cell-free DNA results, Obstet Gynecol., 131, 464, 10.1097/AOG.0000000000002474 Belgian Society of Human Genetics B. Belgian guidelines for managing incidental findings detected by NIPT. 2019. https://www.college-genetics.be/assets/recommendations/fr/guidelines/BELGIAN GUIDELINES FOR MANAGING INCIDENTAL FINDINGS DETECTED BY NIPT (2019).pdf de Haan, 2018, Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients, Lancet Oncol, 19, 337, 10.1016/S1470-2045(18)30059-7 Maggen, 2019, Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study, Lancet Haematol, 6, e551, 10.1016/S2352-3026(19)30195-4 Amant, 2013, Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study, J Clin Oncol, 31, 2532, 10.1200/JCO.2012.45.6335 Halaska, 2019, Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy, Int J Gynecol Cancer, 29, 676, 10.1136/ijgc-2018-000103 Bayindir, 2015, Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management, Eur J Hum Genet, 23, 1286, 10.1038/ejhg.2014.282 Negrini, 2010, Genomic instability an evolving hallmark of cancer, Nat Rev Mol Cell Biol., 11, 220, 10.1038/nrm2858 Paulsson, 2001, The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology, Cancer Genet Cytogenet, 130, 160, 10.1016/S0165-4608(01)00486-1 Han, 2012, Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review, BMC Med, 10, 10.1186/1741-7015-10-86 Han, 2018, Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study, Eur Radiol, 28, 1862, 10.1007/s00330-017-5126-z Maggen, 2019 Paulsson, 2007, Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes, Pathol Biol, 55, 37, 10.1016/j.patbio.2006.04.007 Amant, 2015, Pediatric outcome after maternal cancer diagnosed during pregnancy, N Engl J Med, 373, 1824, 10.1056/NEJMoa1508913 Vandenbroucke, 2017, Effects of cancer treatment during pregnancy on fetal and child development, Lancet Child Adolesc Heal, 1, 302, 10.1016/S2352-4642(17)30091-3 Voulgaris, 2011, Cancer and pregnancy: a comprehensive review, Surg Oncol., 20, e175, 10.1016/j.suronc.2011.06.002 Snyder, 2016, Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling, Prenat Diagn, 36, 203, 10.1002/pd.4778 Hartmann, 2019, Clonal hematopoiesis and preleukemia—Genetics, biology, and clinical implications, Genes Chromosom Cancer, 58, 828, 10.1002/gcc.22756 Lenaerts, 2019, Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors, Ann Oncol, 30, 10.1093/annonc/mdy476 Laurie, 2012, Detectable clonal mosaicism from birth to old age and its relationship to cancer, Nat Genet, 44, 642, 10.1038/ng.2271 Bianchi, 2004, Circulating fetal DNA: its origin and diagnostic potential - a review, Placenta, 10.1016/j.placenta.2004.01.005 Hartwig, 2017, Discordant non-invasive prenatal testing (NIPT) – a systematic review, Prenat Diagn, 37, 527, 10.1002/pd.5049 Van Den Bogaert K., Lannoo L., Brison N., et al. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. doi: 10.1038/s41436-021-01101-4. Lenaerts, 2020, Breast cancer detection and treatment monitoring using a noninvasive prenatal testing platform: utility in pregnant and nonpregnant populations, Clin Chem, 10.1093/clinchem/hvaa196 Liu, 2020, Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA, Ann Oncol, 31, 745, 10.1016/j.annonc.2020.02.011 Snyder, 2016, Cell-free DNA Comprises an in vivo nucleosome footprint that informs its tissues-of-origin, Cell, 164, 57, 10.1016/j.cell.2015.11.050 Peng, 2020, Identifying the tissues-of-origin of circulating cell-free DNAs is a promising way in noninvasive diagnostics, Brief Bioinform Imbert-Bouteille, 2017, An incidental finding of maternal multiple myeloma by non invasive prenatal testing, Prenat Diagn, 37, 1257, 10.1002/pd.5168 Rengifo, 2020, Noninvasive prenatal testing detected acute myeloid leukemia in paucisymptomatic pregnant patient, Clin Case Reports, 10.1002/ccr3.3027